Research Study

A Randomized Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in Acute Bipolar-I Depression
Principal Investigator 
Lakshmi N. Yatham

Overview

Body Locations and Systems 
Disorders and Conditions 
ClinicalTrials.gov# 
NCT02749006
Status 
Recruiting
Study Start/End 
Apr 1, 2016 to Dec 31, 2020
Locations 
UBC Hospital
Name/Title 
Sharon Ahn, Research Assistant
Phone 
604-822-7320
Email Address 
sharon.ahn@ubc.ca
Purpose of Study 

Bipolar-I Disorder is a common condition that is characterized by periods of mood elevation however periods of chronic and recurring depressive episodes are more common and can be severely disabling. Effective treatments exist, however a significant portion of bipolar depressed patients do not respond to, or have difficulty tolerating many of these interventions. Repetitive Transcranial Magnetic Stimulation (rTMS) is a non-invasive neuromodulatory technique that is effective in major depression and there is evidence for its efficacy in bipolar depression which needs to be assessed in larger randomized controlled trials. This study is a randomised, double-blind, sham-controlled trial over four weeks. The primary objective is to assess improvement in depressive symptoms in acute bipolar-I depressed patients on treatment with intermittent Theta-Burst Stimulation (iTBS) in comparison to sham-rTMS.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.